Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Fiero · SciRah

Researcher profile · Semantic Scholar

M. Fiero

Share profile

M. Fiero — researcher profile on SciRah

h-index: 27
Works: 78
Citations: 2,676

Most-cited papers

Handling missing data in RCTs; a review of the top medical journals
M. Bell, M. Fiero, N. Horton, Chiu-Hsieh Hsu
2014BMC Medical Research Methodology348 citations Open access
Semantic Scholar
Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study
M. Bell, D. Fairclough, M. Fiero, P. Butow
2016BMC Research Notes171 citations Open access
Semantic Scholar
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, S. Agrawal, H. Gittleman, M. Fiero +15 more
2022Clinical Cancer Research152 citations Open access
Semantic Scholar
Evaluation of a Web-Based Cognitive Rehabilitation Program in Cancer Survivors Reporting Cognitive Symptoms After Chemotherapy.
V. Bray, H. Dhillon, M. Bell, Michael Kabourakis +5 more
2017Journal of Clinical Oncology149 citations
Semantic Scholar
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations
Luckson N. Mathieu, E. Larkins, Oladimeji Akinboro, Pourab Roy +26 more
2021Clinical Cancer Research120 citations
Semantic Scholar
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer
S. Wahby, L. Fashoyin-Aje, C. Osgood, Joyce Cheng +15 more
2020Clinical Cancer Research115 citations
Semantic Scholar
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop.
P. Kluetz, Bindu Kanapuru, S. Lemery, L. Johnson +24 more
2017Value in Health111 citations Open access
Semantic Scholar
Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors: a randomized, wait list controlled pilot study
S. Dodds, T. Pace, M. Bell, M. Fiero +3 more
2015Supportive Care in Cancer110 citations
Semantic Scholar
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database.
M. Anscher, Shaily Arora, C. Weinstock, Anup K. Amatya +10 more
2022JAMA Oncology109 citations Open access
Semantic Scholar
FDA Approval Summary: Mirvetuximab soravtansine-gynx for FRα-positive, Platinum-Resistant Ovarian Cancer
A. Dilawari, Mirat Shah, G. Ison, H. Gittleman +21 more
2023Clinical Cancer Research98 citations Open access
Semantic Scholar
Statistical analysis and handling of missing data in cluster randomized trials: a systematic review
M. Fiero, Shuang-Li Huang, E. Oren, M. Bell
2016Trials93 citations Open access
Semantic Scholar
Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study
Shuang Huang, M. Fiero, M. Bell
2016Clinical Trials70 citations
Semantic Scholar
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple Negative Breast Cancer.
Mirat Shah, C. Osgood, Anup K. Amatya, M. Fiero +9 more
2022Clinical Cancer Research67 citations Open access
Semantic Scholar
FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
L. Odogwu, Luckson N. Mathieu, K. Goldberg, G. Blumenthal +11 more
2017The Oncologist65 citations Open access
Semantic Scholar
Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials.
J. Roydhouse, M. Fiero, P. Kluetz
2019JAMA Oncology62 citations Open access
Semantic Scholar
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as single agents for first-line treatment of advanced/metastatic PD-L1 high NSCLC.
Oladimeji Akinboro, E. Larkins, L. Pai-Scherf, Luckson N. Mathieu +27 more
2022Clinical Cancer Research60 citations Open access
Semantic Scholar
U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review
Shaily Arora, P. Narayan, C. Osgood, S. Wedam +18 more
2021Clinical Cancer Research57 citations Open access
Semantic Scholar
Impact of caregiver activities and social supports on multidimensional caregiver burden: analyses from nationally-representative surveys of cancer patients and their caregivers
M. Halpern, M. Fiero, M. Bell
2017Quality of Life Research49 citations
Semantic Scholar
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer
Mirat Shah, S. Wedam, Joyce Cheng, M. Fiero +17 more
2020Clinical Cancer Research43 citations Open access
Semantic Scholar
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
Mirat Shah, Hima Lingam, Xin Gao, H. Gittleman +24 more
2024Journal of Clinical Oncology41 citations Open access
Semantic Scholar
High Positive End Expiratory Pressure is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome
C. Bime, M. Fiero, Z. Lu, E. Oren +3 more
2016American Journal of Medicine41 citations Open access
Semantic Scholar
US Food and Drug Administration review of statistical analysis of patient-reported outcomes in lung cancer clinical trials approved between January, 2008, and December, 2017.
M. Fiero, J. Roydhouse, Jonathon Vallejo, B. King-Kallimanis +2 more
2019The Lancet Oncology40 citations Open access
Semantic Scholar
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma
Elaine Chang, C. Weinstock, Li-Jun Zhang, M. Fiero +15 more
2021Clinical Cancer Research38 citations Open access
Semantic Scholar
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
M. Fiero, M. Pe, C. Weinstock, B. King-Kallimanis +6 more
2020The Lancet Oncology38 citations
Semantic Scholar
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Jaleh Fallah, Jianjin Xu, C. Weinstock, M. Brave +19 more
2023Journal of Clinical Oncology37 citations
Semantic Scholar
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma
M. Brave, William F. Maguire, C. Weinstock, Hui Zhang +15 more
2024Clinical Cancer Research33 citations
Semantic Scholar
FDA Approval Summary: Margetuximab plus chemotherapy for advanced or metastatic HER2-positive breast cancer
M. Royce, C. Osgood, Anup K. Amatya, M. Fiero +33 more
2021Clinical Cancer Research29 citations Open access
Semantic Scholar
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
Jaleh Fallah, Brian L. Heiss, Hee-Koung Joeng, C. Weinstock +9 more
2024Clinical Cancer Research27 citations
Semantic Scholar
A pattern-mixture model approach for handling missing continuous outcome data in longitudinal cluster randomized trials
M. Fiero, Chiu-Hsieh Hsu, M. Bell
2017Statistics in Medicine25 citations Open access
Semantic Scholar
Subgroup analyses in oncology trials: regulatory considerations and case examples
Anup K. Amatya, M. Fiero, E. Bloomquist, A. Sinha +14 more
2021Clinical Cancer Research21 citations Open access
Semantic Scholar
Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border
E. Oren, M. Fiero, E. Barrett, B. Anderson +2 more
2016BMC Infectious Diseases21 citations Open access
Semantic Scholar
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.
C. D. Amdal, R. Falk, Ahu Alanya, Michael Schlichting +56 more
2025The Lancet Oncology19 citations Open access
Semantic Scholar
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situ
Brian L. Heiss, Elaine Chang, Hee-Koung Joeng, M. Fiero +16 more
2025Clinical Cancer Research19 citations Open access
Semantic Scholar
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.
M. Fiero, J. Roydhouse, V. Bhatnagar, Ting-Yu Chen +3 more
2022The Lancet Oncology18 citations Open access
Semantic Scholar
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice.
Li-Min Liu, Jungyeon Choi, J. Musoro, W. Sauerbrei +13 more
2023The Lancet Oncology17 citations Open access
Semantic Scholar
Missing data handling in non‐inferiority and equivalence trials: A systematic review
Brooke A. Rabe, S. Day, M. Fiero, M. Bell
2018Pharmaceutical statistics17 citations
Semantic Scholar
U.S. FDA Drug Approvals for Gynecological Malignancies - A Decade in Review
Shaily Arora, P. Narayan, G. Ison, T. Berman +19 more
2021Clinical Cancer Research15 citations Open access
Semantic Scholar
Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes.
M. Bell, M. Fiero, H. Dhillon, V. Bray +1 more
2017Annals of Oncology15 citations Open access
Semantic Scholar
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
Mirat Shah, Ting-Yu Chen, G. Ison, M. Fiero +13 more
2025Journal of Clinical Oncology13 citations
Semantic Scholar
Handling missing values in patient-reported outcome data in the presence of intercurrent events
Doranne Thomassen, Satrajit Roychoudhury, C. D. Amdal, D. Reynders +35 more
2025BMC Medical Research Methodology11 citations Open access
Semantic Scholar
The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology
Doranne Thomassen, Satrajit Roychoudhury, C. D. Amdal, D. Reynders +36 more
2024BMC Medical Research Methodology11 citations Open access
Semantic Scholar
Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study
G. Thanarajasingam, P. Kluetz, V. Bhatnagar, Abbie Brown +17 more
2024BMJ Open9 citations Open access
Semantic Scholar
Statistical analysis and handling of missing data in cluster randomised trials: protocol for a systematic review
M. Fiero, Shuang Huang, M. Bell
2015BMJ Open9 citations Open access
Semantic Scholar
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer.
Asma Dilawari, Hui Zhang, Mirat Shah, Xin Gao +6 more
2025Journal of Clinical Oncology8 citations
Semantic Scholar
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.
Jaleh Fallah, Flora Mulkey, M. Fiero, Haley Gittleman +11 more
2024Journal of Clinical Oncology8 citations
Semantic Scholar
Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis
Asma Dilawari, Mori J Krantz, I. Bulatao, Hee-Koung Joeng +7 more
2025Annals of Noninvasive Electrocardiology6 citations Open access
Semantic Scholar
Erratum to: Feasibility of Cognitively-Based Compassion Training (CBCT) for breast cancer survivors: a randomized, wait list controlled pilot study
S. Dodds, T. Pace, M. Bell, M. Fiero +3 more
2015Supportive Care in Cancer6 citations Open access
Semantic Scholar
FDA Approval Summary: Niraparib Plus Abiraterone Acetate Fixed Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
William F. Maguire, Dow-Chung Chi, S. Agrawal, Hee-Koung Joeng +18 more
2025Clinical Cancer Research4 citations Open access
Semantic Scholar
Integrating 4 Measures to Evaluate Physical Function in Patients with Cancer (In4M): Protocol for a prospective study
G. Thanarajasingam, P. Kluetz, V. Bhatnagar, Abbie Brown +17 more
2023medRxiv4 citations Open access
Semantic Scholar
Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy: A U.S. Food and Drug Administration pooled analysis.
M. Anscher, Shaily Arora, C. Weinstock, Rachael Lubitz +11 more
20204 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Amiri-Kordestani×22
Invite
L. Amiri-Kordestani — researcher profile on SciRah
Sheng-Hui Tang×20
Invite
Sheng-Hui Tang — researcher profile on SciRah
P. Kluetz×20
Invite
P. Kluetz — researcher profile on SciRah
R. Pazdur×17
Invite
R. Pazdur — researcher profile on SciRah

William F. Pierce

×13

Invite

William F. Pierce — researcher profile on SciRah

Invite

M. Bell — researcher profile on SciRah

Invite

J. Beaver — researcher profile on SciRah

Tiffany K Ricks×11

Invite

Tiffany K Ricks — researcher profile on SciRah

V. Bhatnagar×10

Invite

V. Bhatnagar — researcher profile on SciRah

Invite

K. Goldberg — researcher profile on SciRah

Invite

M. Theoret — researcher profile on SciRah

C. Weinstock×7

Invite

C. Weinstock — researcher profile on SciRah